April 2020 Briefing – Gastroenterology
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for April 2020. This roundup includes the latest...
Symptomatic Health Care Staff in U.K. Screened for COVID-19
Shift in transmission dynamics noted as of March 24, concurrent with steps to implement social distancing
GI Manifestations Seen for Nearly One in Three With SARS-CoV-2
Significant portion have diarrhea, nausea, vomiting, and/or abdominal discomfort before respiratory symptoms
David Shulkin, M.D., on COVID-19 Financial Consequences for Health Care System
Shulkin, ninth secretary for Veterans Affairs, estimates health care provider revenue down about $500 billion
David Shulkin, M.D., on COVID-19 Financial Consequences for Health Care System
Shulkin, ninth secretary for Veterans Affairs, estimates health care provider revenue down about $500 billion
Roadmap Developed for Resuming Elective Surgery During COVID-19
Sustained drop in rate of new COVID-19 cases for at least 14 days required to resume elective surgery
Infection Rate Up Prior to Detection of Malignant Cancer
Increased odds of influenza, gastroenteritis, hepatitis, pneumonia seen one year before detection
Scoring System Helps Guide Surgical Care During COVID-19
Twenty-one factors that were significant contributors to procedure triage and prioritization identified
Clinical, Genetic, Biomarker Model IDs Risk for Pancreatic Cancer
Area under the ROC curve estimated by cross-validation was 0.62 for multifactor model
IBD Symptoms in Pregnancy Tied to Higher C-Section Rate, IUGR
Pregnancy less common among women with inflammatory bowel disease
